Limited impact of incorrect data used for list of top 100 ammonia emitters On 1 November 2022, RIVM announced that its list of top-100 ammonia emitters was compiled using incorrect emission factors for some types of livestock housing. RIVM has investigated whether the erroneous data had also been used in other RIVM products.
Annual report ‘Tuberculosis in the Netherlands’ for 2021: slight increase in number of TB patients In 2021, the number of tuberculosis (TB) patients in the Netherlands rose slightly compared to the preceding year: up to 680 TB patients from 622 in 2020. However, the 2021 number was lower than the number for 2019 (754 patients).
No health risks associated with foods and food supplements containing Krill and microalgae oils Consumption of foods and food supplements that contain oil from microalgae Schizochytrium sp. and Krill oil do not cause harm to our health.
No evidence of increased incidence of breast cancer with insulin glargine Insulin glargine is used in the treatment of diabetes.
Lower salt contents in some foods, but similar saturated fat contents Some foods contain less salt in 2014 compared with 2011. According to research by RIVM the salt content of bread was 21 percent lower in 2011.
Risk assessment of dyes and flame retardants; there’s room for improvement On request of the Dutch food and product safety authority, RIVM has developed a prioritization method for substances used in textile production.
RIVM designated as WHO Collaborating Centre Antimicrobial Resistance Epidemiology and Surveillance AMR is one of the major global challenges in infectious disease control.
Comparison of market authorization systems of medical devices in USA and Europe Medical devices are a group of products varying from relatively simple devices like plasters and wheelchairs to complex equipment like pacemakers and MRI scanners.
RIVM researchers win best paper award of the journal Risk Analysis RIVM researchers Arie Havelaar and Arno Swart received the prestigious Best Paper Award 2014 of the Society for Risk Analysis.
Difference in risk assessment of non-threshold carcinogens for workers There is no uniform approach in the European Union for the risk assessment of occupational exposure to non-threshold carcinogens.